NEXUS PRISM
Market Intelligence
Loading validated data…

NEXUS PRISM

Pharma Market Intelligence · by VERIDIQA
Registration is by approval. If your @veridiqa.net email has been approved by the administrator, click Register, then confirm via the email link. Otherwise ask the administrator to add you.

📈 Traffic — admin analytics

👥 Users — admin management

NEXUS PRISM
Pharma Market Intelligence
NEXUS PRISM™ BY VERIDIQA · PREPARED FOR NEXUS PRISM — Portfolio Intelligence · MONTHLY MARKET INTELLIGENCE · V2
A VERIDIQA platform
Portfolio Ranking · Intelligence · Scoring · Management.
Nexus Prism unifies market, sales and regulatory data into one verified base — then refracts it into a clear spectrum of insight: rankings, scores, risks and opportunities.
From Data to Decisions
Validated market audit · PRISM standard · NEXUS PRISM™ by VERIDIQA · prepared for NEXUS PRISM — Portfolio Intelligence · © 2026 Veridiqa

NEXUS PRISM · Index

Ten linked views over the Saudi pharma market — pick where to start.
NEXUS PRISM _Marketing Department

NEXUS PRISM — Market Intelligence

Market Audit · Jun 2026 · YTD · whole-market · PRISM + brand-equity · refreshed monthly
MeasurePeriod YTD · Jun 2026View Sector Scope Company type (multi) ATC1 NEXUS PRISMSaudi nationalInternational genericMultinational

Market dynamics — growth × size (bubble, multi-level drill)

x=growth · y=value(log) · bubble=value · blue ring=NEXUS PRISM. Pick the level, then click any bubble to drill. Sector & company-type filters apply.

🔼 Fastest-growing classes

🔽 Declining classes

⚔️ Most contested (open — weak leader)

🏰 Most locked (dominant leader)

Head-to-Head Lab

Compare side by side. Companies (colour = type), Brands (DIRECT if same ATC4 else INDIRECT), or Molecules. Sector & company-type filters apply to the pick list.

NEXUS PRISM lens — PRISM policy

NEXUS PRISM as one player. PRISM is the decision classification. Sector filter recomputes value & share.

PRISM tier mix

PRISM% vs share

NEXUS PRISM action map — where to grow, defend, convert & enter

NEXUS PRISM's own brands classified for action (PRISM + Evolution Index), Cedar open whitespace. Respects the Sector, Scope & ATC1 filters. Click any row to open the brand or focus the class.

🚀 Grow — top reachable SAR

🛡 Defend — highest value-at-risk

💰 Convert — strong PRISM, low share

🎯 Enter — whitespace (open & growing)

NEXUS PRISM Portfolio Dashboard — every brand vs its ATC4 market

House brand-equity format. Each NEXUS PRISM brand with its relative ATC4 market: players, total market, leader, BE value/units, rank, MS%, brand-equity (vs leader=100%), growth, PRISM. Click a row to open the class & the brands inside it. Sector & value/unit aware.
Column guide (key):
Contribution % = the brand's OWN share of total NEXUS PRISM sales = brand value ÷ total NEXUS PRISM sales. e.g. Cobalt 59.4M ÷ 275.2M = 21.6% · SoleraActiv 21.7M = 7.9% · Cobalt 9.9M = 3.6%. This is the contribution of each Meridian.
Cumul % = the running total of Contribution % added down the sorted list (biggest first). It is NOT a single brand's contribution: e.g. Cobalt's Cumul 54% = Cobalt+…+Cobalt combined, while Cobalt's own contribution is 3.6%. Why it matters (concentration / dependency risk): the row where Cumul passes 80% is your "vital few" (here 17 of 68 brands) — 80% of NEXUS PRISM revenue rides on ~25% of the portfolio. Brands above the 80% Pinnacle = the core to protect & grow; brands in the bottom 5% = the long tail to prune / bundle / streamline. Rising over time = more dependent on fewer brands (riskier); falling = diversifying.
MS% = brand ÷ total ATC4 market · Brand-equity = brand ÷ class leader (leader = 100%) · Mkt GR = the whole class's YoY growth · Brand GR = the NEXUS PRISM brand's own YoY growth (— = no prior-year base) · EI = brand growth ÷ class growth ×100 (>100 gaining share).

Opportunity Radar — Whitespace (where NEXUS PRISM is NOT present yet)

Aurelia entry-opportunity view, separate from the Portfolio Dashboard (which covers your current brands). These are attractive ATC4 classes where NEXUS PRISM has no brand — ranked by an open Opportunity score = market size × growth × openness (lower HHI = more open). All figures are the current Market Audit YTD · Jun 2026. PRISM stays the Meridian classification; this adds market-structure context only. Sector & scope aware.

◎ Whitespace opportunity map — growth × market size (bubble = market openness)

Only classes with no NEXUS PRISM brand are plotted. Up-and-right = big & fast-growing = most attractive to enter. Bigger bubble = more fragmented (lower barrier). Colour = incumbent leader's PRISM strength (greener = weaker leader = easier). Click a bubble to open the class & its leader.

▣ Whitespace — entry targets (ranked)

Key: Opportunity score = (market size, SAR M) × (1 + class growth) × openness (fragmented ×1.3 · moderate ×1.0 · concentrated ×0.7) — a transparent ranking, all raw inputs shown. HHI = class concentration (lower = more fragmented = easier to take share). Leader PRISM = how strong the incumbent #1 is (a MEGA leader is harder to displace). Click any row to open the class & its leader. Polaris aid — validate clinical fit, registration status & supply before committing. For your CURRENT brands & their growth headroom, use the Portfolio Dashboard.

KSA Market Explorer — the whole pharma landscape

The total KSA market by therapy area (ATC1), current Market Audit YTD · Jun 2026. Value & share are YTD; growth is YoY (single-period, honestly labelled — not a multi-year CAGR). Click a bar to drill into that ATC1 in the Funnel. Where NEXUS PRISM plays is highlighted.

Therapy areas (ATC1) by value · YTD

Market share split (ATC1)

360 View — Companies in the KSA pharma league & NEXUS PRISM's place in it

Top companies in KSA by value (YTD Jun-2026), with brand count and PRISM-weighted portfolio strength. Colour = company type. Responds to Sector, Scope & Company-Type filters — values aggregated live from brand-level data (≈95% coverage of the audited company total; NEXUS PRISM exact). Click any company (bar, bubble or row) to open its full portfolio.

Top-20 companies by value · YTD

Portfolio map — brands × value (bubble = PRISM strength)

Strategic groups — price × depth (bubble = sales)

Profit-pool map — therapy areas (bubble = market value)

Brands = how many products a company sells (breadth/size). PRISM strength = value-weighted average Meridian PRISM (portfolio quality 0–100 — how strong each brand is, weighted by sales). Stars = BCG stars · #1 = class leaders. Click any column header to re-sort. Click any company (bar, bubble or row) to open its full portfolio.

Competitive read — breadth × quality, opportunities & threats

Reads the table above for NEXUS PRISM: who is broad-but-weak (attack), who is focused-and-strong (defend), and the direct threats inside NEXUS PRISM's own classes. Respects the Sector, Scope & Company-Type filters.

🎯 Opportunities — attack targets (broad & weak, in our classes)

⚠️ Threats — strong rivals inside our classes

Company H2H — compare any pharma companies side by side

Pick 2–6 companies (NEXUS PRISM ◆ is the anchor). Compare value, brand count, PRISM-weighted portfolio strength, leaders and channel mix — Sector & Scope aware, YTD Jun-2026. Click a company to open its full portfolio. No multi-year CAGR (not in the data) — only metrics the data supports.
Add any company:◆ NEXUS PRISM · ▣ national · ▢ multinational/intl

Value (bars) & PRISM strength (Pinnacle)

Channel mix (Retail / Hospital / Others)

Value = sector/scope-aware, aggregated from brand-level data (≈95% coverage; NEXUS PRISM exact). PRISM strength = value-weighted avg Meridian PRISM (0–100). Channel mix = each company's Retail/Hospital/Others split.

PM 360 — Meridian Manager assessment workbench

A single 360° view per NEXUS PRISM Meridian for the marketing team: Vireo vs last year & vs the market, PRISM evaluation with the path to the next tier and Kestrel potential, direct & indirect competition, share-shift & risk, stress-test scenarios, missed opportunities, data uncertainties, and the required marketing actions to improve or correct — all in one place. Sector/Scope aware · Market Audit YTD Jun-2026.
Meridian Manager Meridian